Annual banned-substance review: Analytical approaches in human sports drug testing 2019/2020.
alternative matrices
doping
mass spectrometry
sport
Journal
Drug testing and analysis
ISSN: 1942-7611
Titre abrégé: Drug Test Anal
Pays: England
ID NLM: 101483449
Informations de publication
Date de publication:
Jan 2021
Jan 2021
Historique:
received:
02
11
2020
accepted:
08
11
2020
pubmed:
14
11
2020
medline:
8
10
2021
entrez:
13
11
2020
Statut:
ppublish
Résumé
Analytical chemistry-based research in sports drug testing has been a dynamic endeavor for several decades, with technology-driven innovations continuously contributing to significant improvements in various regards including analytical sensitivity, comprehensiveness of target analytes, differentiation of natural/endogenous substances from structurally identical but synthetically derived compounds, assessment of alternative matrices for doping control purposes, and so forth. The resulting breadth of tools being investigated and developed by anti-doping researchers has allowed to substantially improve anti-doping programs and data interpretation in general. Additionally, these outcomes have been an extremely valuable pledge for routine doping controls during the unprecedented global health crisis that severely affected established sports drug testing strategies. In this edition of the annual banned-substance review, literature on recent developments in anti-doping published between October 2019 and September 2020 is summarized and discussed, particularly focusing on human doping controls and potential applications of new testing strategies to substances and methods of doping specified the World Anti-Doping Agency's 2020 Prohibited List.
Substances chimiques
Anabolic Agents
0
Diuretics
0
Hormones
0
Illicit Drugs
0
Intercellular Signaling Peptides and Proteins
0
Performance-Enhancing Substances
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
8-35Subventions
Organisme : Manfred-Donike-Institute for Doping Analysis, Cologne, Germany
Organisme : Federal Ministry of the Interior, Building and Community of the Federal Republic of Germany
Informations de copyright
© 2020 The Authors. Drug Testing and Analysis published by John Wiley & Sons Ltd.
Références
Horcajo J, Santos D, Guyer JJ, Moreno L. Changing attitudes and intentions related to doping: an analysis of individual differences in need for cognition. J Sports Sci. 2019;37(24):2835-2843.
Nicholls AR, Levy AR, Meir R, et al. The susceptibles, chancers, pragmatists, and fair players: an examination of the sport drug control model for adolescent athletes, cluster effects, and norm values among adolescent athletes. Front Psychol. 2020;11:1564.
Madigan DJ, Mallinson-Howard SH, Grugan MC, Hill AP. Perfectionism and attitudes towards doping in athletes: a continuously cumulating meta-analysis and test of the 2 × 2 model. Eur J Sport Sci. 2020;20(9):1245-1254. https://doi.org/10.1080/17461391.2019.1698660
Stanger N, Whitaker L, Backhouse SH. Testing the validity and reliability of the doping willingness in sport scale. Scand J Med Sci Sports. 2020;30(8):1529-1543.
Nicholls AR, Madigan DJ, Duncan L, et al. Cheater, cheater, pumpkin eater: the dark triad, attitudes towards doping, and cheating behaviour among athletes. Eur J Sport Sci. 2020;20(8):1124-1130.
Boardley ID, Smith AL, Ntoumanis N, Gucciardi DF, Harris TS. Perceptions of coach doping confrontation efficacy and athlete susceptibility to intentional and inadvertent doping. Scand J Med Sci Sports. 2019;29(10):1647-1654.
Smith ACT, Stavros C. Exploring the progressive use of performance enhancing substances by high-performance athletes. Subst Use Misuse. 2020;55(6):914-927.
Fallace P, Aiese P, Bianco E, et al. Peer education strategies for promoting prevention of doping in different populations. Ann Ig. 2019;31(6):556-575.
Henning A, McLean K, Andreasson J, Dimeo P. Risk and enabling environments in sport: systematic doping as harm reduction. Int J Drug Policy. 2020;102897.
World Anti-Doping Agency. The 2020 prohibited list; 2019. https://www.wada-ama.org/sites/default/files/wada_2020_english_prohibited_list_0.pdf (04-12-2019)
Handelsman DJ. Performance enhancing hormone doping in sport. In: Feingold KR, Anawalt B, Boyce A, et al., eds. Endotext. South Dartmouth (MA): MDText.com; 2000.
Smith ACT, Stavros C, Westberg K. Cognitive enhancing drugs in sport: current and future concerns. Subst Use Misuse. 2020;55(12):2064-2075.
Zhu Z, Zhou J, Manor B, Wang X, Fu W, Liu Y. Commentary: “brain-doping,” is it a real threat? Front Physiol. 2019;10:1489.
Aguilar-Navarro M, Munoz-Guerra J, Del Mar Plara M, Del Coso J. Analysis of doping control test results in individual and team sports from 2003 to 2015. J Sport Health Sci. 2020;9(2):160-169.
Aguilar-Navarro M, Salinero JJ, Munoz-Guerra J, Plata MDM, Del Coso J. Sport-specific use of doping substances: analysis of World Anti-Doping Agency doping control tests between 2014 and 2017. Subst Use Misuse. 2020;55(8):1361-1369.
Fedoruk MN. Virtual drug testing: redefining sample collection in a global pandemic. Bioanalysis. 2020;12(11):715-718.
Garzinsky AM, Thomas A, Krug O, Thevis M. Probing for the presence of doping agents in exhaled breath using chromatographic-mass spectrometric approaches. Rapid Commun Mass Spectrom. 2020;e8939.
Kintz P, Gheddar L, Ameline A, Arbouche N, Raul JS. Hair testing for doping agents. What is known and what remains to do. Drug Test Anal. 2020;12(3):316-322.
Thevis M, Knoop A, Schaefer MS, et al. Can dried blood spots (DBS) contribute to conducting comprehensive SARS-CoV-2 antibody tests? Drug Test Anal. 2020;12(7):994-997.
Garzinsky AM, Walpurgis K, Krug O, Thevis M. Does oral fluid contribute to exhaled breath samples collected by means of an electret membrane? Drug Test Anal. 2019;11(11-12):1764-1770.
Gheddar L, Raul JS, Kintz P. Testing for stanozolol, using UPLC-MS/MS and confirmation by UPLC-q-TOF-MS, in hair specimens collected from 5 different anatomical regions. J Anal Toxicol. 2020. https://doi.org/10.1093/jat/bkaa023
Thevis M, Walpurgis K, Thomas A. Analytical approaches in human sports drug testing-recent advances, challenges, and solutions. Anal Chem. 2020;92(1):506-523.
Hopker J, Griffin J, Brookhouse J, Peters J, Schumacher YO, Iljukov S. Performance profiling as an intelligence-led approach to antidoping in sports. Drug Test Anal. 2020;12(3):402-409.
Walpurgis K, Thomas A, Geyer H, Mareck U, Thevis M. Dietary supplement and food contaminations and their implications for doping controls. Foods. 2020;9:1012. https://doi.org/10.3390/foods9081012
CBC Sports. Canoe star Laurence Vincent Lapointe found not guilty of taking banned substance. 2020, https://www.cbc.ca/sports/olympics/summer/canoe-kayak/laurence-vincent-lapointe-doping-verdict-1.5441395 (27-07-2020)
United States Anti-Doping Agency. U.S. boxing athlete Virginia Fuchs found not at fault; 2020. https://www.usada.org/sanction/virginia-fuchs-found-not-at-fault/ (17-09-2020)
World Anti-Doping Agency. Summary of major modifications and explanatory notes; 2020. https://www.wada-ama.org/sites/default/files/wada_2020_english_summary_of_modifications_.pdf (17-09-2020)
World Anti-Doping Agency. The 2020 monitoring program; 2020. https://www.wada-ama.org/sites/default/files/wada_2020_english_monitoring_program_.pdf (17-09-2020)
Salamin O, Garcia A, Gonzalez-Ruiz V, et al. Is pain temporary and glory forever? Detection of tramadol using dried blood spot in cycling competitions. Drug Test Anal. 2020. https://doi.org/10.1002/dta.2923
Bejder J, Breenfeldt Andersen A, Bonne TC, et al. Tramadol does not improve performance or impair motor function in trained cyclists. Med Sci Sports Exerc. 2020;52(5):1169-1175.
Diel P. Caffeine and doping-what have we learned since 2004. Nutrients. 2020;12(8).
Baltazar-Martins G, Munoz G, Carreras D, Plata MDM, Munoz-Guerra J, Del Coso J. The use of tramadol in combination with pseudoephedrine and caffeine in sports. Drug Test Anal. 2020;12(8):1203-1205.
Baltazar-Martins JG, Plata MDM, Munoz-Guerra J, Munoz G, Carreras D, Del Coso J. Infographic. Tramadol: should it be banned in athletes while competing, particularly in road cycling? Br J Sports Med. 2020;54(2):120-121.
Thevis M, Kuuranne T, Geyer H. Annual banned-substance review-analytical approaches in human sports drug testing. Drug Test Anal. 2020;12(1):7-26.
Ganesan K, Rahman S, Zito PM. Anabolic steroids. Treasure Island (FL): StatPearls; 2020.
Yu JG, Isaksson A, Rova A, Tegner Y, Eriksson A, Malm C. Potential effects of long-term abuse of anabolic androgen steroids on human skeletal muscle. J Sports Med Phys Fitness. 2020;60(7):1040-1048.
Christoffersen T, Andersen JT, Dalhoff KP, Horwitz H. Anabolic-androgenic steroids and the risk of imprisonment. Drug Alcohol Depend. 2019;203:92-97.
Tlili R, Zayed S, Saoudi W, Azaiez F, Hentati R, Ben Ameur Y. Adverse cardiovascular effects of doping in athletes. Tunis Med. 2019;97(11):1211-1218.
Perez Palacios D, Giraldez Gallego A, Carballo Rubio V, Sola Fernandez A, Pascasio Acevedo JM. Drug-induced liver injury due to mesterolone: a case report. Gastroenterol Hepatol. 2019;42(10):629-630.
Middlebrook I, Schoener B. Anabolic Steroid Toxicity. Treasure Island (FL): StatPearls; 2020.
Kahal A, Allem R, Zahzeh T, Oulmane S, Tafroukhte Z. Abuse of androgenic anabolic drugs with “cycling” induces hepatic steatosis in adult male mice. Steroids. 2020;155:108574.
Richardson A, Antonopoulos GA. Anabolic-androgenic steroids (AAS) users on AAS use: negative effects, ‘code of silence’, and implications for forensic and medical professionals. J Forensic Leg Med. 2019;68:101871.
Lehmann S, Thomas A, Schiwy-Bochat KH, et al. Death after misuse of anabolic substances (clenbuterol, stanozolol and metandienone). Forensic Sci Int. 2019;303:109925.
Araujo MP. Androgen abuse among recreational athletes. Rev Bras Ginecol Obstet. 2019;41(12):679-681.
Smit DL, de Hon O, Venhuis BJ, den Heijer M, de Ronde W. Baseline characteristics of the HAARLEM study: 100 male amateur athletes using anabolic androgenic steroids. Scand J Med Sci Sports. 2020;30(3):531-539.
Borjesson A, Lehtihet M, Andersson A, et al. Studies of athlete biological passport biomarkers and clinical parameters in male and female users of anabolic androgenic steroids and other doping agents. Drug Test Anal. 2020;12(4):514-523.
World Anti-Doping Agency. 2018 anti-doping testing figures; 2019. https://www.wada-ama.org/sites/default/files/resources/files/2018_testing_figures_report.pdf (21-09-2020)
Jancic-Stojanovic B, Göschl L, Forsdahl G, Gmeiner G. Metabolism of steroids and sport drug testing. Bioanalysis. 2020. https://doi.org/10.4155/bi-2020-0077:epub
Georgakopoulos C. Detecting-the 2004 Athens Olympic games. Drug Test Anal. 2020;12(5):641-646.
Sobolevsky T, Ahrens B. High-throughput liquid chromatography tandem mass spectrometry assay as initial testing procedure for analysis of total urinary fraction. Drug Test Anal. 2020. https://doi.org/10.1002/dta.2917
World Anti-Doping Agency. Minimum required performance levels for detection and identification of non-threshold substances; 2019. https://www.wada-ama.org/sites/default/files/resources/files/td2019mrpl_eng.pdf (04-12-2019)
Fragkaki AG, Petropoulou G, Athanasiadou I, et al. Determination of anabolic androgenic steroids as imidazole carbamate derivatives in human urine using liquid chromatography-tandem mass spectrometry. J Sep Sci. 2020;43(11):2154-2161.
Maddox SW, Olsen SSH, Velosa DC, Burkus-Matesevac A, Peverati R, Chouinard CD. Improved identification of isomeric steroids using the Paterno-Buchi reaction with ion mobility-mass spectrometry. J Am Soc Mass Spectrom. 2020;31(10):2086-2092. https://doi.org/10.1021/jasms.0c00215
Minhas RS, Rudd DA, Al Hmoud HZ, Guinan TM, Kirkbride KP, Voelcker NH. Rapid detection of anabolic and narcotic doping agents in saliva and urine by means of nanostructured silicon SALDI mass spectrometry. ACS Appl Mater Interfaces. 2020;12(28):31195-31204.
Protti M, Marasca C, Cirrincione M, Sberna AE, Mandrioli R, Mercolini L. Dried urine microsampling coupled to liquid chromatography-tandem mass spectrometry (LC-MS/MS) for the analysis of unconjugated anabolic androgenic steroids. Molecules. 2020;25(14):3210. https://doi.org/10.3390/molecules25143210
Kratena N, Biedermann N, Stojanovic B, et al. Synthesis of a human long-term oxymetholone metabolite. Steroids. 2019;150:108430.
Shostko DY, Liubina AI, Kozyrkov YY, Beliaev SA. The synthesis of 4-chloro-17beta-hydroxymethyl-17alpha-methyl-18-norandrosta-4,13-diene-3alpha-ol-proposed long term metabolite (M4) of oralturinabol. Steroids. 2020;158:108601.
Goschl L, Gmeiner G, Enev V, Kratena N, Gartner P, Forsdahl G. Development and validation of a simple online-SPE method coupled to high-resolution mass spectrometry for the analysis of stanozolol-N-glucuronides in urine samples. Drug Test Anal. 2020;12(8):1031-1040.
Martinez-Brito D, Iannone M, Tatangelo MA, Molaioni F, De la Torre X, Botre F. A further insight on methyltestosterone metabolism: new evidences from in vitro and in vivo experiments. Rapid Commun Mass Spectrom. 2020;34(19):e8870. https://doi.org/10.1002/rcm.8870:e8870
Sakellariou P, Kiousi P, Fragkaki AG, et al. Alternative markers for methylnortestosterone misuse in human urine. Drug Test Anal. 2020. https://doi.org/10.1002/dta.2887
Piper T, Fußhöller G, Schänzer W, Lagojda A, Kühne D, Thevis M. Studies on the in vivo metabolism of methylstenbolone and detection of novel long term metabolites for doping control analysis. Drug Test Anal. 2019;11(11-12):1644-1655.
Putz M, Piper T, Thevis M. Identification of trenbolone metabolites using hydrogen isotope ratio mass spectrometry and liquid chromatography/high accuracy/high resolution mass spectrometry for doping control analysis. Front Chem. 2020;8:435.
Polet M, Van Gansbeke W, Albertsdottir AD, Coppieters G, Deventer K, Van Eenoo P. Gas chromatography-mass spectrometry analysis of non-hydrolyzed sulfated steroids by degradation product formation. Drug Test Anal. 2019;11(11-12):1656-1665.
Albertsdottir AD, Van Gansbeke W, Coppieters G, Balgimbekova K, Van Eenoo P, Polet M. Searching for new long-term urinary metabolites of metenolone and drostanolone using gas chromatography-mass spectrometry with a focus on non-hydrolysed sulfates. Drug Test Anal. 2020;12(8):1041-1053.
Narduzzi L, Dervilly G, Audran M, Le Bizec B, Buisson C. A role for metabolomics in the antidoping toolbox? Drug Test Anal. 2020;12(6):677-690.
Mullen J, Baekken LV, Tormakangas T, et al. Inter-individual variation of the urinary steroid profiles in Swedish and Norwegian athletes. Drug Test Anal. 2020;12(6):720-730.
Amante E, Pruner S, Alladio E, Salomone A, Vincenti M, Bro R. Multivariate interpretation of the urinary steroid profile and training-induced modifications. The case study of a Marathon runner. Drug Test Anal. 2019;11(10):1556-1565.
Cornu C, Grange C, Regalin A, et al. Effect of non-steroidal anti-inflammatory drugs on sport performance indices in healthy people: a meta-analysis of randomized controlled trials. Sports Med Open. 2020;6:20.
Stoll A, Iannone M, De Gregorio G, de la Torre X, Botre F, Parr M. Influence of pain killers on the urinary anabolic steroid profile. J Anal Toxicol. 2020. https://doi.org/10.1093/jat/bkaa1049
World Anti-Doping Agency. Endogenous anabolic androgenic steroids-measurement and reporting; 2018. https://www.wada-ama.org/sites/default/files/resources/files/td2018eaas_final_eng.pdf (25-09-2019)
Mazzarino M, Martellone L, Comunita F, de la Torre X, Molaioni F, Botre F. Detection of 5alpha-reductase inhibitors by UPLC-MS/MS: application to the definition of the excretion profile of dutasteride in urine. Drug Test Anal. 2019;11(11-12):1737-1746.
Iannone M, Palermo A, de la Torre X, et al. Effects of transdermal administration of testosterone gel on the urinary steroid profile in hypogonadal men: implications in antidoping analysis. Steroids. 2019;152:108491.
Sim J, Cho B, Park M, Rhee J, In S, Choe S. Monitoring urinary testosterone and epitestosterone levels, and their ratio, in Korean chemical castration subjects using liquid chromatography-tandem mass spectrometry. J Anal Toxicol. 2020;44(2):192-199.
Saad K, Vonaparti A, Athanasiadou I, et al. Population reference ranges of urinary endogenous sulfate steroids concentrations and ratios as complement to the steroid profile in sports antidoping. Steroids. 2019;152:108477.
Forsdahl G, Zanitzer K, Erceg D, Gmeiner G. Quantification of endogenous steroid sulfates and glucuronides in human urine after intramuscular administration of testosterone esters. Steroids. 2020;157:108614.
De Wilde L, Roels K, Van Renterghem P, Van Eenoo P, Deventer K. Steroid profiling in urine of intact glucuronidated and sulfated steroids using liquid chromatography-mass spectrometry. J Chromatogr a. 2020;1624:461231.
Iannone M, Botre F, Martinez-Brito D, Matteucci R, de la Torre X. Development and application of analytical procedures for the GC-MS/MS analysis of the sulfates metabolites of anabolic androgenic steroids: the pivotal role of chemical hydrolysis. J Chromatogr B Analyt Technol Biomed Life Sci. 2020;1155:122280.
Salamin O, Ponzetto F, Cauderay M, et al. Development and validation of an UHPLC-MS/MS method for extended serum steroid profiling in female populations. Bioanalysis. 2020;12(11):753-768.
Elmongy H, Masquelier M, Ericsson M. Development and validation of a UHPLC-HRMS method for the simultaneous determination of the endogenous anabolic androgenic steroids in human serum. J Chromatogr a. 2020;1613:460686.
Handelsman DJ, Bermon S. Detection of testosterone doping in female athletes. Drug Test Anal. 2019;11(10):1566-1571.
Chang WC, Cowan DA, Walker CJ, Wojek N, Brailsford AD. Determination of anabolic steroids in dried blood using microsampling and gas chromatography-tandem mass spectrometry: application to a testosterone gel administration study. J Chromatogr a. 2020;1628:461445.
Van Renterghem P, Viaene W, Van Gansbeke W, et al. Validation of an ultra-sensitive detection method for steroid esters in plasma for doping analysis using positive chemical ionization GC-MS/MS. J Chromatogr B Analyt Technol Biomed Life Sci. 2020;1141:122026.
Segura J, Ventura R, Pascual JA, de la Torre R. If you play with fire, you may get burned. Drug Test Anal. 2020;12(5):582-587.
Montes de Oca Porto R, Fernandez Hormiga MA, Correa Vidal MT, Martinez Brito D. Carbon isotope ratio of endogenous urinary steroids of the Cuban population of athletes studied for doping purposes. Drug Test Anal. 2020;12(10):1501-1507. https://doi.org/10.1002/dta.2898
de Oliveira FA, Casilli A, Piper T, et al. Implementation and performance of the gas chromatography/combustion/isotope ratio mass spectrometry-based method for the confirmatory analysis of endogenous anabolic steroids during the Rio de Janeiro Olympic and Paralympic games 2016. Anal Chem. 2019;91(18):11747-11756.
Putz M, Piper T, Dubois M, Delahaut P, Thevis M. Analysis of endogenous steroids in urine by means of multi-immunoaffinity chromatography and isotope ratio mass spectrometry for sports drug testing. Anal Bioanal Chem. 2019;411(28):7563-7571.
De Wilde L, Van Renterghem P, Van Eenoo P, Polet M. Development and validation of a fast gas chromatography combustion isotope ratio mass spectrometry method for the detection of epiandrosterone sulfate in urine. Drug Test Anal. 2020;12(8):1006-1018.
Piper T, Fussholler G, Geyer H, Toboc A, Danila MG, Thevis M. Detecting the misuse of 7-oxo-DHEA by means of carbon isotope ratio mass spectrometry in doping control analysis. Rapid Commun Mass Spectrom. 2020;34:e8776.
Martinez-Brito D, de la Torre X, Colamonici C, Curcio D, Botre F. 7-keto-DHEAmetabolism in humans. Pitfalls in interpreting the analytical results in the antidoping field. Drug Test Anal. 2019;11(11-12):1629-1643.
Christiansen AR, Lipshultz LI, Hotaling JM, Pastuszak AW. Selective androgen receptor modulators: the future of androgen therapy? Transl Androl Urol. 2020;9(Suppl 2):S135-S148.
Giagulli VA, Silvestrini A, Bruno C, Triggiani V, Mordente A, Mancini A. Is there room for SERMs or SARMs as alternative therapies for adult male hypogonadism? Int J Endocrinol. 2020;2020:9649838.
da Fonseca GWP, Dworatzek E, Ebner N, Von Haehling S. Selective androgen receptor modulators (SARMs) as pharmacological treatment for muscle wasting in ongoing clinical trials. Expert Opin Investig Drugs. 2020;29(8):881-891. https://doi.org/10.1080/13543784.13542020.11777275
Leaney AE, Beck P, Biddle S, et al. Analysis of supplements available to UK consumers purporting to contain selective androgen receptor modulators. Drug Test Anal. 2020. https://doi.org/10.1002/dta.2908
Gadaj A, Ventura E, Healy J, et al. Enhanced UHPLC-MS/MS screening of selective androgen receptor modulators following urine hydrolysis. MethodsX. 2020;7:100926.
Ventura E, Gadaj A, Buckley T, Mooney MH. Investigation of stability of selective androgen receptor modulators in urine. Food Addit Contam Part a Chem Anal Control Expo Risk Assess. 2020;37:1253-1263.
Walpurgis K, Rubio A, Wagener F, et al. Elimination profiles of microdosed ostarine mimicking contaminated products ingestion. Drug Test Anal. 2020;12. https://doi.org/10.1002/dta.2933
Kintz P, Gheddar L, Ameline A, Raul JS. Identification of S22 (ostarine) in human nails and hair using LC-HRMS. Application to two authentic cases. Drug Test Anal. 2020;12(10):1508-1513.
Jessen S, Solheim SA, Jacobson GA, et al. Beta2-adrenergic agonist clenbuterol increases energy expenditure and fat oxidation, and induces mTOR phosphorylation in skeletal muscle of young healthy men. Drug Test Anal. 2020;12(5):610-618.
World Anti-Doping Agency. Stakeholder notice regarding meat contamination; 2019. https://www.wada-ama.org/sites/default/files/resources/files/2019-05-30-meat_contamination_notice_final.pdf (08-10-2019)
Solheim SA, Jessen S, Morkeberg J, et al. Single-dose administration of clenbuterol is detectable in dried blood spots. Drug Test Anal. 2020;12(9):1366-1372. https://doi.org/10.1002/dta.2872
He G, Sheng L, Zhang J, et al. Enantiomeric analysis of clenbuterol in Chinese people by LC-MS/MS to distinguish doping abuse from meat contamination. Bioanalysis. 2020;12(11):783-790.
Trinh KV, Diep D, Chen KJQ, Huang L, Gulenko O. Effect of erythropoietin on athletic performance: a systematic review and meta-analysis. BMJ Open Sport Exerc Med. 2020;6:e000716.
Heiland CE, Masquelier M, Bhuiyan H, Ericsson M. A simple method to immunopurify erthyropoiesis stimulating agents from urine, aiming to optimize erythropoietin screening by SAR-PAGE. Drug Test Anal. 2019;11(11-12):1666-1674.
Zhou X, Zhang L, He S, Shen L, He C. Comparison and optimization of SAR-PAGE tests for erythropoietins in doping analysis. Drug Test Anal. 2020;12(1):109-118.
Zhou X, He S, Zhang L, Shen L, He C. Research on spiking rat EPO as internal standard in doping control samples for detection of EPO using SAR-PAGE analysis with biotinylated primary antibody. Drug Test Anal. 2020;12(8):1054-1064.
Martin L, Martin JA, Collot D, et al. Improved detection methods significantly increase the detection window for EPO microdoses. Drug Test Anal. 2020. https://doi.org/10.1002/dta.2904
Bejder J, Robach P, Lundby AK, et al. Low doses of recombinant human erythropoietin does not affect C-terminal FGF23 in healthy men. Drug Test Anal. 2020;12(7):975-979.
Robach P, Gammella E, Recalcati S, et al. Induction of erythroferrone in healthy humans by micro-dose recombinant erythropoietin or high-altitude exposure. Haematologica. 2020. https://doi.org/10.3324/haematol.2019.233874
Ramirez Cuevas K, Schobinger C, Gottardo E, et al. Erythroferrone as a sensitive biomarker to detect stimulation of erythropoiesis. Drug Test Anal. 2020;12(2):261-267.
Salamin O, Gottardo E, Schobinger C, et al. Detection of stimulated erythropoiesis by the RNA-based 5'-Aminolevulinate synthase 2 biomarker in dried blood spot samples. Clin Chem. 2019;65(12):1563-1571.
Gorgens C, Guddat S, Bosse C, Knoop A, Geyer H, Thevis M. Implementation of the HIF activator IOX-2 in routine doping controls-pilot study data. Drug Test Anal. 2020. https://doi.org/10.1002/dta.2914
Lawley JS, Gatterer H, Dias KA, et al. Safety, hemodynamic effects, and detection of acute xenon inhalation: rationale for banning xenon from sport. J Appl Physiol (1985). 2019;127:1511-1518.
Dias KA, Lawley JS, Gatterer H, et al. Effect of acute and chronic xenon inhalation on erythropoietin, hematological parameters, and athletic performance. J Appl Physiol (1985). 2019;127:1503-1510.
Knoop A, Görgens C, Geyer H, Thevis M. Elevated urinary cobalt concentrations identified in routine doping controls can originate from vitamin B12. Rapid Commun Mass Spectrom. 2020;34:e8649.
De Santi M, Baldelli G, Brandi G. Gsms-SitI WGoMSfHISoHpM, public H, Wdpp WGDPP. Use of hormones in doping and cancer risk. Ann Ig. 2019;31(6):590-594.
Ho KKY. The promise of growth hormone in sport: doped or duped. Arch Endocrinol Metab. 2019;63(6):576-581.
Marchand A, Martin JA, Collot D, et al. Combined administration of microdoses of growth hormone and erythropoietin: effects on performance and evaluation of GH detection capability using anti-doping methods. Drug Test Anal. 2019;11(11-12):1698-1713.
Moncrieffe D, Cox HD, Carletta S, et al. Inter-laboratory agreement of insulin-like growth factor 1 concentrations measured intact by mass spectrometry. Clin Chem. 2020;66(4):579-586.
Coppieters G, Judak P, Van Haecke N, Van Renterghem P, Van Eenoo P, Deventer K. A high-throughput assay for the quantification of intact insulin-like growth factor I in human serum using online SPE-LC-HRMS. Clin Chim Acta. 2020;510:391-399.
Mongongu C, Moussa EM, Semence F, et al. Use of capillary dried blood for quantification of intact IGF-I by LC-HRMS for antidoping analysis. Bioanalysis. 2020;12(11):737-752.
Marchand A, Roulland I, Semence F, Audran M. Volumetric absorptive microsampling (VAMS) technology for IGF-1 quantification by automated chemiluminescent immunoassay in dried blood. Growth Horm IGF Res. 2020;50:27-34.
Narduzzi L, Dervilly G, Marchand A, Audran M, Le Bizec B, Buisson C. Applying metabolomics to detect growth hormone administration in athletes: proof of concept. Drug Test Anal. 2020;12(7):887-899.
Lange T, Thomas A, Walpurgis K, Thevis M. Fully automated dried blood spot sample preparation enables the detection of lower molecular mass peptide and non-peptide doping agents by means of LC-HRMS. Anal Bioanal Chem. 2020;412(15):3765-3777.
Thomas A, Thevis M. Identification of metabolites of peptide-derived drugs using an isotope-labeled reporter ion screening strategy. Clin Chem Lab Med. 2020;58(5):690-700.
Makela R, Leinonen A, Suominen T. Analysis of luteinizing hormone (LH): validation of a commercial ELISA kit for LH analysis and quantification in doping control samples. Drug Test Anal. 2020;12(2):239-246.
Riiser A, Stensrud T, Stang J, Andersen LB. Aerobic performance among healthy (non-asthmatic) adults using beta2-agonists: a systematic review and meta-analysis of randomised controlled trials. Br J Sports Med. 2020. https://doi.org/10.1136/bjsports-2019-100984
Hafedh H, Slimani M, Miarka B, Bettayeb R, Bragazzi NL. Effects of terbutaline sulfate on physiological and biomechanical as well as perceived exertion in healthy active athletes: a pilot study. J Hum Kinet. 2019;69:169-178.
Lemminger AK, Jessen S, Habib S, et al. Effect of beta2-adrenergic agonist and resistance training on maximal oxygen uptake and muscle oxidative enzymes in men. Scand J Med Sci Sports. 2019;29(12):1881-1891.
Riiser A, Stensrud T, Stang J, Andersen LB. Can beta2-agonists have an ergogenic effect on strength, sprint or power performance? Systematic review and meta-analysis of RCTs. Br J Sports Med. 2020;54(22):1351-1359. https://doi.org/10.1136/bjsports-2019-100708
Merlini M, Whyte G, Marcora S, Loosemore M, Chester N, Dickinson J. Improved sprint performance with inhaled long-acting beta2-agonists combined with resistance exercise. Int J Sports Physiol Perform. 2019;14:1344-1349.
Hostrup M, Jacobson GA, Jessen S, Lemminger AK. Anabolic and lipolytic actions of beta2-agonists in humans and antidoping challenges. Drug Test Anal. 2020;12(5):597-609.
Merlini M, Beato M, Marcora S, Dickinson J. The effect of 1600 mug inhaled salbutamol administration on 30 m sprint performance pre and post a Yo-Yo intermittent running test in football players. J Sports Sci Med. 2019;18(4):716-721.
World Anti-Doping Agency. Decision limits for the confirmatory quantification of threshold substances; 2019. https://www.wada-ama.org/sites/default/files/resources/files/td2019dl_v2_finalb.pdf (04-12-2019)
Jacobson GA, Hostrup M. The salmeterol anomaly and the need for a urine threshold. Drug Test Anal. 2020. https://doi.org/10.1002/dta.2810
Okano M, Miyamoto A, Sato M, Kageyama S. Analysis of tretoquinol and its metabolites in human urine by liquid chromatography-tandem mass spectrometry. Drug Test Anal. 2019;11(11-12):1724-1730.
Yen CC, Tung CW, Chang CW, Tsai CC, Hsu MC, Wu YT. Potential risk of higenamine misuse in sports: evaluation of lotus Plumule extract products and a human study. Nutrients. 2020;12(2):285. https://doi.org/10.3390/nu12020285
Yan K, Wang X, Wang Z, et al. The risk of higenamine adverse analytical findings following oral administration of plumula nelumbinis capsules. Drug Test Anal. 2019;11(11-12):1731-1736.
Wang R, Xiong X, Yang M, He S, Xu X. A pharmacokinetics study of orally administered higenamine in rats using LC-MS/MS for doping control analysis. Drug Test Anal. 2020;12(4):485-495.
Feng YR, Wang B, Li GJ, Kang WJ, Lian KQ, Lu XL. Determination of higenamine in multi-matrix by gas chromatography-mass spectrometry combined with derivatization technology. J Food Drug Anal. 2020;28(1):124-131.
Nuntawong P, Tanaka H, Sakamoto S, Morimoto S. ELISA for the detection of the prohibited doping agent higenamine. Planta Med. 2020;86(11):760-766.
Sardela VF, Sardela PDO, Lisboa RR, et al. Comprehensive zebrafish water tank experiment for metabolic studies of testolactone. Zebrafish. 2020;17(2):104-111.
Martinez Brito D, de la Torre X, Botre F. Detection of urinary metabolites of arimistane in humans by gas chromatography coupled to high accuracy mass spectrometry for antidoping analyses. Rapid Commun Mass Spectrom. 2019;33(24):1894-1905.
Iannone M, Botre F, Parenti S, Jardines D, de la Torre X. An investigation on the metabolic pathways of synthetic isoflavones by gas chromatography coupled to high accuracy mass spectrometry. Rapid Commun Mass Spectrom. 2019;33(19):1485-1493.
Reichel C, Gmeiner G, Thevis M. Detection of black market follistatin 344. Drug Test Anal. 2019;11(11-12):1675-1697.
Walpurgis K, Weigand T, Knoop A, et al. Detection of follistatin-based inhibitors of the TGF-beta signaling pathways in serum/plasma by means of LC-HRMS/MS and western blotting. Drug Test Anal. 2020;12. https://doi.org/10.1002/dta.2925
Walpurgis K, Thomas A, Thevis M. Detection of the myostatin-neutralizing antibody domagrozumab in serum by means of western blotting and LC-HRMS. Drug Test Anal. 2019;11(11-12):1714-1723.
Kintz P, Ameline A, Gheddar L, Raul JS. Testing for GW501516 (cardarine) in human hair using LC/MS-MS and confirmation by LC/HRMS. Drug Test Anal. 2020;12(7):980-986.
Goergens C, Walker K, Boeser C, et al. Paper spray mass spectrometry-a potential complementary technique for the detection of polar compounds in sports drug testing. Drug Test Anal. 2020. https://doi.org/10.1002/dta.2909
Mazzarino M, Senofonte M, Martinelli F, de la Torre X, Botre F. Detection of recombinant insulins in human urine by liquid chromatography-electrospray ionization tandem mass spectrometry after immunoaffinity purification based on monolithic microcolumns. Anal Bioanal Chem. 2019;411(30):8153-8162.
Judak P, Coppieters G, Lapauw B, Van Eenoo P, Deventer K. Urinary detection of rapid-acting insulin analogs in healthy humans. Drug Test Anal. 2020.12(11-12). https://doi.org/10.1002/dta.2817
Thomas A, Yang R, Petring S, Bally L, Thevis M. Simplified quantification of insulin, its synthetic analogs and C-peptide in human plasma by means of LC-HRMS. Drug Test Anal. 2020;12(3):382-390.
Hemmersbach P. The probenecid-story-a success in the fight against doping through out-of-competition testing. Drug Test Anal. 2020;12(5):589-594.
Lutter C, Tischer T, El-Sheikh Y, Schoffl V. Doping in sport climbing: status quo in a new Olympic discipline. Curr Sports Med Rep. 2019;18(10):351-352.
Rossini EL, Kulyk DS, Ansu-Gyeabourh E, Sahraeian T, Pezza HR, Badu-Tawiah AK. Direct analysis of doping agents in raw urine using hydrophobic paper spray mass spectrometry. J Am Soc Mass Spectrom. 2020;31(6):1212-1222.
Walpurgis K, Scheiff AB, Welz M, et al. Pilot study on the effects of intravesical oxybutynin hydrochloride instillations on the validity of doping control urine samples. Drug Test Anal. 2019;11(11-12):1755-1760.
Baltazar-Martins G, Del Mar Plata M, Munoz-Guerra J, Argaya J, Del Coso J. Chronicle of an unintentional MDMA intoxication of a field hockey team to prevent its qualification for the Beijing 2008 Olympics: a case report. Drug Test Anal. 2020;12(5):647-650.
Camuto C, Pellegrini S, De-Giorgio F, et al. Urinary excretion profile of methiopropamine in mice following intraperitoneal administration: a liquid chromatography-tandem mass spectrometry investigation. Drug Test Anal. 2020. https://doi.org/10.1002/dta.2900
Dib J, Bosse C, Tsivou M, et al. Is heptaminol a (major) metabolite of octodrine? Drug Test Anal. 2019;11(11-12):1761-1763.
Olesti E, Pascual JA, Ventura M, et al. LC-MS/MS method for the quantification of new psychoactive substances and evaluation of their urinary detection in humans for doping control analysis. Drug Test Anal. 2020;12(6):785-797.
Thevis M, Kuuranne T, Dib J, Thomas A, Geyer H. Do dried blood spots (DBS) have the potential to support result management processes in routine sports drug testing? Drug Test Anal. 2020;12(6):704-710.
Vernec A, Slack A, Harcourt PR, et al. Glucocorticoids in elite sport: current status, controversies and innovative management strategies-a narrative review. Br J Sports Med. 2020;54(1):8-12.
Redon B, Violleau C, Georges F, Marsicano G, Chaouloff F. The ergogenic impact of the glucocorticoid prednisolone does not translate into increased running motivation in mice. Psychoneuroendocrinology. 2020;111:104489.
Coll S, Monfort N, Matabosch X, et al. Budesonide use and misuse in sports: elimination profiles of budesonide and metabolites after intranasal, high-dose inhaled and oral administrations. Drug Test Anal. 2020;12(5):629-636.
Athanasiadou I, Vonaparti A, Dokoumetzidis A, et al. Effect of hyperhydration on the pharmacokinetics and detection of orally administered budesonide in doping control analysis. Scand J Med Sci Sports. 2019;29:1489-1500.
Coll S, Monfort N, Alechaga E, Matabosch X, Perez-Mana C, Ventura R. Additional studies on triamcinolone acetonide use and misuse in sports: elimination profile after intranasal and high-dose intramuscular administrations. Steroids. 2019;151:108464.
Coll S, Matabosch X, Llorente-Onaindia J, et al. Elimination profile of triamcinolone hexacetonide and its metabolites in human urine and plasma after a single intra-articular administration. Drug Test Anal. 2019;11(11-12):1589-1600.
Mazzarino M, Piantadosi C, Comunita F, de la Torre X, Botre F. Urinary excretion profile of prednisone and prednisolone after different administration routes. Drug Test Anal. 2019;11(11-12):1601-1614.
World Anti-Doping Agency. WADA technical letter-TL19: in situ formation of prednisone and prednisolone; 2019. https://www.wada-ama.org/sites/default/files/resources/files/tl19v2_prednisone_and_prednisolone.pdf (26-10-2020)
Iannella L, Botre F, Colamonici C, Curcio D, de la Torre X. Development and validation of a method to confirm the exogenous origin of prednisone and prednisolone by GC-C-IRMS. Drug Test Anal. 2019;11(11-12):1615-1628.
Iannella L, Botre F, Colamonici C, et al. Carbon isotopic characterization of prednisolone and prednisone pharmaceutical formulations: implications in antidoping analysis. Drug Test Anal. 2020. https://doi.org/10.1002/dta.2876
McCartney D, Benson MJ, Desbrow B, Irwin C, Suraev A, McGregor IS. Cannabidiol and sports performance: a narrative review of relevant evidence and recommendations for future research. Sports Med Open. 2020;6(1):27.
Gamelin FX, Cuvelier G, Mendes A, et al. Cannabidiol in sport: ergogenic or else? Pharmacol Res. 2020;156:104764.
Lachenmeier DW, Diel P. A warning against the negligent use of cannabidiol in professional and amateur athletes. Sports (Basel). 2019;7(12):251. https://doi.org/10.3390/sports7120251
Kasper AM, Sparks SA, Hooks M, et al. High prevalence of cannabidiol use within male professional Rugby union and league players: a quest for pain relief and enhanced recovery. Int J Sport Nutr Exerc Metab. 2020;30(5):315-322. https://doi.org/10.1123/ijsnem.2020-0151
Pacifici R, Pichini S, Pellegrini M, et al. THC and CBD concentrations in blood, oral fluid and urine following a single and repeated administration of “light cannabis”. Clin Chem Lab Med. 2020;58(5):682-689.
Atkinson TS, Kahn MJ. Blood doping: then and now. A narrative review of the history, science and efficacy of blood doping in elite sport. Blood Rev. 2020;39:100632.
Saugy M, Leuenberger N. Antidoping: from health tests to the athlete biological passport. Drug Test Anal. 2020;12(5):621-628.
Mahendru D, Kumaravel J, Mahalmani VM, Medhi B. Athlete biological passport: need and challenges. Indian J Orthop. 2020;54(3):264-270.
Iljukov S, Kauppi JP, Uusitalo ALT, Peltonen JE, Schumacher YO. Association between implementation of the athlete biological passport and female elite runners' performance. Int J Sports Physiol Perform. 2020;15(9):1231-1236. https://doi.org/10.1123/ijspp.2019-0643
Faiss R, Saugy J, Zollinger A, et al. Prevalence estimate of blood doping in elite track and field athletes during two major international events. Front Physiol. 2020;11:160.
Astolfi T, Schumacher YO, Crettaz von Roten F, Saugy M, Faiss R. Does body position before and during blood sampling influence the athlete biological passport variables? Int J Lab Hematol. 2020;42(1):61-67.
Mullen J, Baekken L, Bergstrom H, Bjorkhem Bergman L, Ericsson M, Ekstrom L. Fluctuations in hematological athlete biological passport biomarkers in relation to the menstrual cycle. Drug Test Anal. 2020;12(9):1229-1240. https://doi.org/10.1002/dta.2873
Athanasiadou I, Christian Voss S, El Saftawy W, Al-Maadheed M, Valsami G, Georgakopoulos C. Hyperhydration using different hydration agents does not affect the haematological markers of the athlete biological passport in euhydrated volunteers. J Sports Sci. 2020;38(16):1924-1932.
Coffman KE, Mitchell KM, Salgado RM, Miller GD, Kenefick RW, Cheuvront SN. Potential for dehydration to impact the athlete biological passport. Drug Test Anal. 2020;12(8):1206-1211.
Miller GD, Beharry A, Teramoto M, Lai A, Willick SE, Eichner D. Hematological changes following an ironman triathlon: an anti-doping perspective. Drug Test Anal. 2019;11(11-12):1747-1754.
Garvican-Lewis LA, Lobigs LM, Equey T, et al. A multi-parametric approach to remove the influence of plasma volume on the athlete biological passport during a union Cycliste Internationale cycling stage race. Drug Test Anal. 2020;12(9):1252-1263. https://doi.org/10.1002/dta.2878
Voss SC, Al-Hamad K, Samsam W, et al. A novel mixed living high training low intervention and the hematological module of the athlete biological passport. Drug Test Anal. 2020;12(3):323-330.
Solheim SA, Morkeberg J, Dehnes Y, et al. Changes in blood parameters after intramuscular testosterone ester injections-implications for anti-doping. Drug Test Anal. 2020;12(8):1019-1030.
Bejder J, Gurdeniz G, Cuparencu C, et al. An untargeted urine metabolomics approach for autologous blood transfusion detection. Med Sci Sports Exerc. 2020. https://doi.org/10.1249/MSS.0000000000002442
Aikin R, Baume N, Equey T, Rabin O. Biomarkers of doping: uses, discovery and validation. Bioanalysis. 2020;12(11):791-800.
Nunes AJ, Paixao P, Proenca J, Silva R. Early warning of suspected doping from biological passport based on multivariate trends. Int J Sports Med. 2020;41(1):44-53.
Cox HD. Dried blood spots may improve detection of blood doping. Clin Chem. 2019;65(12):1481-1483.
Bizjak DA, Grolle A, Urena JAN, Bloch W, Deitenbeck R, Grau M. Monitoring of RBC rheology after cryopreservation to detect autologous blood doping in vivo? A pilot study. Clin Hemorheol Microcirc. 2020;1-13. https://doi.org/10.3233/CH-200887
Schmidt WFJ, Hoffmeister T, Haupt S, Schwenke D, Wachsmuth NB, Byrnes WC. Chronic exposure to low-dose carbon monoxide alters hemoglobin mass and V O2max. Med Sci Sports Exerc. 2020;52(9):1879-1887.
The Royal Swedish Academy of Sciences. The Nobel Prize in Chemistry 2020; 2020. https://www.nobelprize.org/uploads/2020/10/press-chemistryprize2020.pdf (28-10-2020)
Al-Khelaifi F, Yousri NA, Diboun I, et al. Genome-wide association study reveals a novel association between MYBPC3 gene polymorphism, endurance athlete status, aerobic capacity and steroid metabolism. Front Genet. 2020;11:595.
Baoutina A. A brief history of the development of a gene doping test. Bioanalysis. 2020;12(11):723-727.
Cantelmo RA, Da Silva AP, Mendes-Junior CT, Dorta DJ. Gene doping: present and future. Eur J Sport Sci. 2019;1-9.
Lopez S, Meirelles J, Rayol V, et al. Gene doping and genomic science in sports: where are we? Bioanalysis. 2020;12(11):801-811.
Aoki K, Sugasawa T, Yanazawa K, et al. The detection of trans gene fragments of hEPO in gene doping model mice by Taqman qPCR assay. PeerJ. 2020;8:e8595.